India to Congo: Levodopa Carbidopa Export Trade Route

The India to Congo Levodopa Carbidopa corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $109 USD. The route is dominated by RUSHI MARKETING, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's levodopa carbidopa manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $55 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 21.5%, placing it at rank #5 among India's top levodopa carbidopa export destinations globally.

On the import side, key buyers of Indian levodopa carbidopa in Congo include S JARS COMMUNE DE. S JARS COMMUNE DE is the single largest importer with 2 shipments valued at $109 USD.

India's levodopa carbidopa exports to Congo are driven primarily by a handful of large-scale manufacturers. RUSHI MARKETING with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Congo benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — RUSHI MARKETING — together account for 100% of total trade value on this route. The average shipment value of $55 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, S JARS COMMUNE DE is the largest importer with 2 shipments worth $109 USD — representing 100% of all levodopa carbidopa imports from India on this route.